American International Group, Inc. An2 Therapeutics, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.94 - $15.6 $849 - $1,669	107 Added 2.04%	5,362 $52,000
Q4 2022 Feb 10, 2023	BUY	$8.51 - $19.69 $25,325 - $58,597	2,976 Added 130.58%	5,255 $50,000
Q3 2022 Nov 14, 2022	BUY	$7.61 - $22.29 $821 - $2,407	108 Added 4.97%	2,279 $40,000
Q2 2022 Aug 12, 2022	BUY	$7.7 - $18.82 $16,716 - $40,858	2,171 New	2,171 $17,000

13.8M

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $21.9M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.